Morepen Laboratories Limited (BOM:500288)
56.59
+2.80 (5.21%)
At close: Jul 27, 2026
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 31.01 billion as of July 27, 2026. Its market cap has decreased by -5.59% in one year.
Market Cap
31.01B
Enterprise Value
32.18B
Revenue
18.06B
Ranking
n/a
PE Ratio
32.71
Stock Price
56.59
ChartMarket Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 31.01B, an increase of 258.15%. That is a compound annual growth rate of 4.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 31.01B | 37.79% |
| Dec 31, 2025 | 22.50B | -47.55% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 67.94B |
| Bliss GVS Pharma | 48.89B |
| Novartis India | 40.23B |
| Gufic Biosciences | 38.26B |
| Unichem Laboratories | 38.26B |
| Kwality Pharmaceuticals | 28.15B |
| Hikal | 27.39B |
| Venus Remedies | 20.98B |